Corticotropin-Releasing Hormone and Opioid Peptides in Reproduction and Stress

References

• Selye H. Stress. Acta, Montreal 1950
   Google Scholar
• Cross B A. Neurohormonal mechanisms in emotional inhibition of milk ejection. J Endocrinol 1955; 12: 29–37
   PubMedGoogle Scholar
• Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41 -residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 1981; 78: 1394–7
   Google Scholar
• Sforzo G A. Opioids and Exercise. An Update. Sports Medicine 1988; 7: 109–24
   Google Scholar
• Kaufman J-M, Kesner J S, Wilson R C, Knobil E. Electrophysiological manifestation of luteinizing hormone-releasing hormone pulse generator activity in the rhesus monkey: influence of alfa-adrenergic and dopaminergic blocking agents Endocrinology 1985; 116: 1327–33
   Google Scholar
• Jarry H, Perschl A, Wuttke W. Further evidence that preoptic anterior hypothalamic GABAergic neurons are part of the GnRH pulse and surge generator. Acta Endocrinol (Copenh) 1988; 118: 573–9
   PubMedGoogle Scholar
• Nikolarakis K E, Almeida O FX, Herz A. Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor. Neuroendocrinology 1988; 47: 545–50
   PubMedGoogle Scholar
• Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 1986; 131: 607–9
   Google Scholar
• Hoffman P. Endogenous opioid effects elicited by muscle activity. An attempt to explain cardiovascular, analgesic and behavioural mechanisms of exercise. M.D. Thesis, Göteborg 1990; 1–59
   Google Scholar
• Pertovaara A, Huopaniemi T, Virtanen A, Johansson G. The influence of exercise on dental pain thresholds and the release of stress hormones. Physiol & Behav 1984; 33: 923–6
   PubMed Web of Science ®Google Scholar
• Haier R J, Quaid K, Mills J SC. Naloxone alters pain perception after jogging. Psychiatry Res 1981; 5: 231–2
   PubMed Web of Science ®Google Scholar
• Olausson B, Eriksson E, Ellmarker L, Rydenhag B, Shyu B-C, Andersson S A. Effects of naloxone on dental pain threshold following muscle exercise and low frequency transcutaneous nerve stimulation: a comparative study in man. Acta Physiol Scand 1986; 126: 299–305
   PubMedGoogle Scholar
• Grossman A, Moult P JA, Cunnah D, Besser G M, Sutton J. The role of opioid peptides in the hormonal responses to acute exercise. Clin Sci 1984; 67: 483–91
   PubMed Web of Science ®Google Scholar
• Farrell P A, Gustafson A B, Garthwaite T L, Kalkhoff R K, Cowley A W, Jr, Morgan W P. Influence of endogenous opioids on the response of selected hormones to exercise in humans. J Appl Physiol 1986; 61: 1051–7
   PubMed Web of Science ®Google Scholar
• Howlett T A. Hormonal responses to exercise and training: A short review. Clin Endocrinol 1987; 26: 723–42
   PubMed Web of Science ®Google Scholar
• Carr D B, Bullen B A, Skrinar G S, et al. Physical conditioning facilitates the exercise-induced secretion of β-endorphin and β-lipotropin in women. N Engl J Med 1981; 305: 560–3
   PubMed Web of Science ®Google Scholar
• Howlett T A, Tomlin S, Ngahfoong L, et al. Release of β-endorphin and met-enkephalin during exercise in normal women: response to training. Brit Med J 1984; 288: 1950–2
   PubMed Web of Science ®Google Scholar
• Luger A, Deuster P, Kyle S, et al. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. N Engl J Med 1987; 316: 1309–15
   PubMed Web of Science ®Google Scholar
• Chandra A M, Patra P B, Chatterjee P, Deb C. Adrenocortical activity in female rats following long-term exposure to treadmill running. Endokrinologie 1978; 72: 139–42
   Google Scholar
• Warren M P. The effects of exercise on pubertal progression and reproductive function in girls. J Clin Endocrinol Metab 1980; 51: 1150–7
   PubMed Web of Science ®Google Scholar
• Shangoid M M. Exercise and amenorrhea. Sem Reprod Endocrinol 1985; 3: 35–41
   Google Scholar
• Bullen B A, Skrinar G S, Beitins I Z, von Mering G, Turnbull B A, MacArthur J W. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 1985; 312: 1349–53
   PubMed Web of Science ®Google Scholar
• Cumming D C, Vickovic M M, Wall S R, Fluker M R. Defects in pulsatile LH release in normally menstruating runners. J Clin Endocrinol Metab 1985; 60: 810–12
   PubMed Web of Science ®Google Scholar
• Veldhuis J D, Evans W S, Demers L M, Thorner M O, Wakat D, Rogol A D. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab 1985; 61: 557–63
   PubMed Web of Science ®Google Scholar
• Cumming D C, Vickovic M M, Wall S R, Fluker M R, Belcastro A N. The effect of acute exercise on pulsatile release of luteinizing hormone in women runners. Am J Obstet Gynecol 1985; 153: 482–5
   PubMed Web of Science ®Google Scholar
• Sauder S E, Case G D, Hopwood N J, Keich R P, Marshall J C. The effects of opiate antagonism on gonadotropin secretion in children and in women with hypothalamic amenorrhea. Pediatr Res 1984; 18: 322–8
   PubMedGoogle Scholar
• Wildt L, Leyendecker G. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea. J Clin Endocrinol Metab 1987; 64: 1334–5
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Virtanen T, Apter D. Plasma immunoreactive β-endorphin in exercise-associated amenorrhea. Am J Obstet Gynecol 1986; 154: 94–7
   PubMedGoogle Scholar
• Ding J H, Sheckter C B, Drinkwater B L, Soules M R, Bremner W J. High serum cortisol levels in exercise associated amenorrhea. Ann Intern Med 1988; 50: 530–5
   Google Scholar
• Hohtari H, Elovainio R, Salminen K, Laatikainen T. Plasma corticotropin-releasing hormone, corticotropin, and endorphins at rest and during exercise in eumenorrheic and amenorrheic athletes. Fertil Steril 1988; 50: 233–8
   PubMedGoogle Scholar
• Hohtari H, Salmlnen-Lappalainen K, Laatikainen T. Response of plasma endorphins, corticotropin, cortisol, and luteinizing hormone in the corticotropin-releasing hormone stimulation test in eumenorrheic and amenorrheic athletes. Fertil Steril 1991; 55: 276–80
   PubMedGoogle Scholar
• Smith N J. Excessive weight loss and food aversion in athletes simulating anorexia nervosa. Pediatrics 1980; 66: 139–42
   PubMed Web of Science ®Google Scholar
• Schwartz B, Cumming D C, Riordan E, Selye M, Yen S SC, Rebar R W. Exercise-associated amenorrhea: a distinct entity?. Am J Obstet Gynecol 1981; 141: 662–70
   PubMed Web of Science ®Google Scholar
• Grossman A, Moult P JA, McIntyre H, et al. Opiate mediation of amenorrhea in hyperprolactinaemia and in weight-loss related amenorrhea. Clin Endocrinol (Oxf) 1982; 17: 379–88
   PubMed Web of Science ®Google Scholar
• Wardlaw S L, Wehrenberg W B, Ferin M, Antunes J L, Franz A G. Effect of sex steroids on ß-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab 1982; 55: 877–81
   PubMed Web of Science ®Google Scholar
• Veldhuis J D, Rogol A D, Samojlik E, Ertel N H. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. J Clin Invest 1984; 74: 47–55
   PubMedGoogle Scholar
• Wehrenberg W B, Wardlaw S L, Frantz A G, Ferin M. β-endorphin in hypophyseal portal blood: variations throughout the menstrual cycle. Endocrinology 1982; 111: 879–81
   PubMed Web of Science ®Google Scholar
• Ropert J F, Quigley M E, Yen S SC. Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J Clin Endocrinol Metab 1981; 52: 583–5
   PubMed Web of Science ®Google Scholar
• Blankstein J, Reyes F I, Winter J SD, Faiman C. Endorphins and the regulation of the human menstrual cycle. Clin Endocrinol (Oxf) 1981; 14: 287–94
   PubMed Web of Science ®Google Scholar
• Cetel N S, Quigley M E, Yen S SC. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids. J Clin Endocrinol Metab 1985; 60: 191–6
   PubMedGoogle Scholar
• Rossmanith W G, Mortola J F, Yen S SC. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women. J Clin Endocrinol Metab 1988; 67: 695–700
   PubMed Web of Science ®Google Scholar
• Sirinathsinghji D JS, Motta M, Martini L. Induction of precocious puberty in the female rat after chronic naloxone administration during the neonatal period: the opiate “brake” on prepubertal gonadotropin secretion. J Endocrinol 1985; 104: 299–307
   PubMedGoogle Scholar
• Petraglia F, Bernasconi S, Lughetti L, et al. Naloxone-induced luteinizing hormone secretion in normal precocious and delayed puberty. J Clin Endocrinol Metab 1986; 63: 1112–6
   PubMedGoogle Scholar
• Shoupe D, Montz F J, Lobo R A. The effects of estrogens and progestins on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab 1985; 60: 178–83
   PubMed Web of Science ®Google Scholar
• Reid R L, Yen S SC. Premenstrual syndrome. Am J Obstet Gynecol 1981; 139: 85–104
   PubMed Web of Science ®Google Scholar
• Chuong C J, Coulam C B, Bergstrahl E J, O'Fallon W M, Steinmetz G I. Clinical trial of naltrexone in premenstrual syndrome. Obstet Gynecol 1988; 72: 332–6
   PubMed Web of Science ®Google Scholar
• Giannini A J, Sullivan B, Sarachene J, Loiselle R H. Clonidine in the treatment of premenstrual syndrome: a subgroup study. J Clin Psychiatry 1988; 49: 62–3
   PubMedGoogle Scholar
• Suda T, Tomori N, Yajima F, Sumimoto T, Nakagami Y, Ushiyama T, Demura H, Shizume K. Immunorective corticotropin-releasing factor in human plasma. J Clin Invest 1985; 76: 2026–9
   PubMedGoogle Scholar
• Sasaki A, Sato S, Murakami O, et al. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources. J Clin Endocrinol Metab 1987; 65: 176–82
   PubMedGoogle Scholar
• Watabe T, Tanaka K, Kumagae M, et al. Hormonal responses to insulin-induced hypoglycemia in man. J Clin Endocrinol Metab 1987; 65: 1187–91
   PubMed Web of Science ®Google Scholar
• Orth D N, Mount C D. Specific affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Comm 1987; 143: 411–7
   PubMed Web of Science ®Google Scholar
• Rahkila P, Hakala E, Alén M, Salminen K, Laatikainen T. β-Endorphin and corticotropin release is dependent on a threshold intensity of running exercise in male endurance athletes. Life Sci 1988; 43: 551–8
   PubMed Web of Science ®Google Scholar
• Meirleir K, de Naaktgeboren N, Steirteghem A V, Gorus F, Olbrecht J, Block P. Beta-endorphin and ACTH levels in peripheral blood during and after aerobic and anaerobic exercise. Eur J Appl Physiol 1986; 55: 5–8
   Google Scholar
• Vrbicky K W, Baumstark J S, Wells I C, Hilgers T W, Kable W T, Elias C J. Evidence for the involvement of ß-endorphin in the human menstrual cycle. Fertil Steril 1982; 38: 701–4
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Räisänen I, Tulenheimo A, Salminen K. Plasma β-endorphin and the menstrual cycle. Fertil Steril 1985; 44: 206–9
   PubMed Web of Science ®Google Scholar
• Comotini G, Petraglia F, Facchinetti F, Monaco M, Volpe A, Genazzani A R. Effect of oral contraceptives or dexamethasone on plasma β-endorphin during the menstrual cycle. Fertil Steril 1989; 51: 46–50
   PubMedGoogle Scholar
• Petraglia F, Di Meo G, De Leo V, Nappi C, Facchinetti F, Genazzani A R. Plasma β-endorphin levels in anovulatory states: changes after treatment for the induction of ovulation. Fertil Steril 1986; 45: 185–90
   PubMedGoogle Scholar
• Genazzani A R, Facchinetti F, Ricci-Danero M G, et al. β-Lipotropin and β-endorphin in physiological and surgical menopause. J Endocrinol Invest 1981; 4: 375–378
   PubMed Web of Science ®Google Scholar
• Genazzani A R, Facchinetti F, Pintor C, et al. Proopiocortin-related peptide plasma levels throughout puberty and prepuberty. J Clin Endocrinol Metab 1983; 57: 56–61
   PubMedGoogle Scholar
• Chuong C J, Coulam C B, Kao P C, Bergstralh E J, Go V LW. Neuropeptide levels in premenstrual syndrome. Fertil Steril 1985; 44: 760–5
   PubMed Web of Science ®Google Scholar
• Tulenheimo A, Laatikainen T, Salminen K. Plasma β-endorphin immunoreactivity in premenstrual tension. Br J Obstet Gynaecol 1987; 94: 26–9
   PubMedGoogle Scholar
• Tsong S D, Phillips D, Halmi N, et al. ACTH and β-endorphin are present in multiple sites in the reproductive tract in the male rat. Endocrinology 1982; 110: 2204–6
   PubMed Web of Science ®Google Scholar
• Fabbri A, Jannini E A, Gnessi L, Ulisse S, Moretti C, Isidori A. Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sites. J Steroid Biochem 1989; 32(1B)145–50
   PubMedGoogle Scholar
• Bardin C W, Shaha C, Mather J, et al. Identification and possible function of pro-opiomelanocortin-derived peptides in rat testis. Ann NY Acad Sci 1984; 438: 346–64
   PubMedGoogle Scholar
• Morris P L, Vale W W, Bardin C W. β-endorphin regulation of FSH-stimulated inhibin production is a component of a short loop system in testis. Biochem Biophys Res Comm 1987; 148: 1513–9
   PubMedGoogle Scholar
• Shaha C, Margioris A, Liotta A S, Krieger D T, Bardin C W. Demonstration of immunorective β-endorphin and gamma3-melanocyte-stimulating hormone-related peptides in the ovaries of neonatal, cycling and pregnant mice. Endocrinology 1984; 115: 378–84
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Salminen K, Wahlström T. β-Endorphin and β-lipotropin in human ovary. Neuropeptides 1986; 8: 251–8
   PubMedGoogle Scholar
• Aleem F A, Eltabbak G H, Omar R A, Southern A L. Ovarian follicular fluid β-endorphin levels in normal and polycystic ovaries. Am J Obstet Gynecol 1987; 156: 1197–200
   PubMedGoogle Scholar
• Gintzler A R. Endorphin-mediated increases in pain threshold during pregnancy. Science 1980; 210: 193–5
   PubMed Web of Science ®Google Scholar
• Wardlaw S L, Frantz A G. Brain β-endorphin during pregnancy, parturition, and postpartum period. Endocrinology 1983; 113: 1664–8
   PubMed Web of Science ®Google Scholar
• Steinbrook R A, Carr D B, Detta S, Naulty J S, Lee C, Fisher J. Dissociation of plasma and cerebrospinal fluid beta-endorphin-like immunoreactivity levels during pregnancy and parturition. Anesth Analg 1982; 61: 893–7
   PubMedGoogle Scholar
• Wakerley J B, Noble R, Clarke G. Effects of morphine and D-Ala-D-Leu enkephalin on the electrical activity of supraoptic neurosecretory cells in vitro. Neuroscience 1983; 10: 73–81
   PubMedGoogle Scholar
• Bicknell R J, Zhao B-G. Secretory terminals of oxytocin release as a site of opioid modulation. Brain opioid systlems in reproduction, R G Dyer, R J. Bicknell. Oxford University Press, Oxford 1989; 285–307
   Google Scholar
• Shibasaki T, Odagiri E, Shizume K, Ling N. Corticotropin-releasing factor-like activity in human placental extracts. J Clin Endocrinol Metab 1982; 55: 384–6
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Saijonmaa O, Salminen K, Wahlström T. Localization and concentrations of β-endorphin and β-lipotropin in human placenta. Placenta 1987; 8: 381–7
   PubMedGoogle Scholar
• Saijonmaa O, Laatikainen T, Wahlström T. Corticotropin-releasing factor in human placenta: Localization, concentration and release in vitro 1988; 9: 373–85
   Google Scholar
• Robinson B G, Emanuel R L, Frim D M, Majzoub J A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988; 85: 5244–8
   PubMed Web of Science ®Google Scholar
• Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989; 160: 247–51
   PubMed Web of Science ®Google Scholar
• Sasaki A, Liotta A S, Luckey M M, Margiorls A N, Suda T, Krieger D T. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy. J Clin Endocrinol Metab 1984; 59: 812–4
   PubMed Web of Science ®Google Scholar
• Campbell E A, Llnton E A, Wolfe C DA, Scraggs P R, Jones M T, Lowry P J. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987; 64: 1054–9
   PubMed Web of Science ®Google Scholar
• Laatikainen T J, Räisänen I J, Salminen K. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal maturation. Am J Obstet Gynecol 1988; 159: 891–5
   PubMed Web of Science ®Google Scholar
• Orth D N, Mount C D. Specific high affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biophys Biophys Res Comm 1987; 143: 411–7
   PubMed Web of Science ®Google Scholar
• Salminen-Lappalainen K, Laatikainen T. Binding of corticotropin-releasing hormone (CRH) in maternal and fetal plasma and in amniotic fluid. Clin Chim Acta 1990; 195: 57–66
   PubMed Web of Science ®Google Scholar
• Räisänen I. Plasma levels and diurnal variation of β-endorphin, β-lipotropin and corticotropin during pregnancy and early puerperium. Eur J Obstet Gynecol Reprod Biol 1988; 27: 13–20
   PubMed Web of Science ®Google Scholar
• Sasaki A, Shinkawa O, Yoshinaga K. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. J Clin Invest 1989; 84: 1997–2001
   PubMed Web of Science ®Google Scholar
• Ackland J F, Ratter S J, Bourne G L, Rees L H. Corticotropin-releasing factor-like imrnunoreactivity and bioactivity of human fetal and adult hypothalami. J Endocrinol 1986; 108: 171–80
   PubMed Web of Science ®Google Scholar
• Blumenfield Z, Jaffe E B. Mypophysiotropic and neuromodulatory regulation of adrenocorticotropin in the human fetal pituitary gland. J Clin Invest 1986; 78: 288–94
   PubMedGoogle Scholar
• Wintour E M, Bell R J, Carson R S, et al. Effect of long-term infusion of ovine corticotropin-releasing factor in the immature ovine fetus. J Endocrinol 1986; 111: 469–79
   PubMedGoogle Scholar
• Petraglia F, Sawchenko P E, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987; 328: 717–9
   PubMed Web of Science ®Google Scholar
• Jones A, Challis J RG. Effects of Corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol Obstet Invest 1990; 29: 165–8
   PubMed Web of Science ®Google Scholar
• Quartero H WP, Fry C H. Placental corticotropin releasing factor may modulate human parturition. Placenta 1989; 10: 439–43
   PubMed Web of Science ®Google Scholar
• Wolfe C DA, Patel S P, Linton E A, et al. Plasma corticotropin-releasing factor (CRF) in abnormal pregnancies. Br J Obstet Gynaecol 1988; 95: 1003–6
   PubMedGoogle Scholar
• Laatikainen T, Virtanen T, Kaaja R, Salminen-Lappalainen K. Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia. Eur J Obstet Gynecol and Reprod Biol 1991; 39: 19–24
   PubMed Web of Science ®Google Scholar
• Räisänen I, Salminen K, Laatikainen T. Response of plasma immunoreactive β-endorphin and corticotropin to isometric exercise in uncomplicated pregnancy and in pregnancy-induced hypertension. Eur J Obstet Gynecol and Reprod Biol 1990; 35: 119–24
   PubMed Web of Science ®Google Scholar
• Goland R S, Wardlaw S L, Blum M, Tropper P J, Stark R I. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am J Obstet Gynecol 1988; 159: 884–90
   PubMed Web of Science ®Google Scholar
• Räisänen I, Paatero H, Salminen K, Laatikainen T. Pain and plasma β-endorphin level during labor. Obstet Gynecol 1984; 64: 783–6
   PubMed Web of Science ®Google Scholar
• Räisänen I, Paatero H, Salminen K, Laatikainen T. β-Endorphin in maternal and umbilical cord plasma at elective cesarean section and in spontaneous labor. Obstet Gynecol 1986; 67: 384–7
   PubMedGoogle Scholar
• Wardlaw S L, Stark R L, Baxi L, Frantz A C. Plasma β-endorphin and β-lipotropin in the human fetus at delivery: correlation with arterial pH and PO2. J Clin Endocrinol Metab 1979; 49: 888–91
   PubMed Web of Science ®Google Scholar
• Petraglia F, Volpe A, Genazzani A R, Rivier J, Sawchenko P E, Vale W. Neuroendocrinology of the human placenta. Frontiers in Neuroendocrinology 1990; 11: 6–37
   Web of Science ®Google Scholar
• Smith R, Owens P C, Brinsmead M W, Singh B, Hall C. The nonsuppressiblity of plasma cortisol persists after pregnancy. Horm Metab Res 1987; 19: 41–2
   PubMedGoogle Scholar
• Selmanoff M, Gregerson K A. Suckling-induced prolactin release is suppressed by naloxone and stimulated by beta-endorphin. Neuroendocrinology 1986; 42: 255–9
   PubMedGoogle Scholar
• Taya K, Sasamoto S. Inhibitory effects of corticotropin-releasing factor and beta-endorphin on LH and FSH secretion in the lactating rat. J Endocrinol 1989; 120: 509–15
   PubMedGoogle Scholar
• Gordon K, Renfree M B, Short R V, Clarke I J. Hypothalamo-pituitary portal blood concentrations of beta-endorphin during suckling in the ewe. J Reprod Fertil 1987; 79: 397–408
   PubMedGoogle Scholar
• Cholst I N, Wardlaw S L, Newman C B, Frantz A G. Prolactin response to breast stimulation in lactating women is not mediated by endogenous opioids. Am J Obstet Gynecol 1984; 150: 558–61
   PubMedGoogle Scholar
• Genazzani A R, Facchinetti F, Parrinl D, et al. Puerperal breast feeding does not stimulate circulating opioids in humans. J Endocrinol Invest 1982; 5: 367–71
   PubMedGoogle Scholar
• Tulenheimo A R, Räisänen I J, Salminen K R, Laatikainen T J. Plasma immunoreactive β-endorphin in the early puerperium and during suckling. J Obstet Gynaecol 1985; 6: 47–50
   Google Scholar
• Smith R, Cubis J, Brinsmead M, et al. Mood changes, obstetric experience and alterations in plasma cortisol, beta-endorphin and corticotropin releasing hormone during pregnancy and the puerperium. J Psychosom Res 1990; 34: 53–69
   PubMed Web of Science ®Google Scholar